Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
CNS Pharmaceuticals, Inc
(Exact Name of Registrant as Specified in its Charter)
Table 1-Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration |
Equity | Common Stock, $0.001 par value | Rule 457(c) and Rule 457(h) | 745,800(2) | $2.54(3) | $1,894,332(3) | 0.00014760 | $279.60 |
Total Offering Amounts | $1,894,332 | $279.60 | |||||
Total Fee Offsets(4) | - | ||||||
Net Fee Due | $279.60 |
(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers any additional shares of common stock of CNS Pharmaceuticals, Inc. (the “Registrant”) that may be granted under the CNS Pharmaceuticals, Inc. 2020 Stock Plan, as amended (the “2020 Plan”) to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2) Represents 745,800 shares of Registrant’s common stock that were added to the shares reserved for issuance under the 2020 Plan.
(3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h)) of the Securities Act of 1933, as amended, and based on $2.54 per share, the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on November 20, 2023.
(4) We do not have any fee offsets.